Microsoft Joins ADVOCATE Program, Names New Asia Co-Presidents

Microsoft is contributing AI technology to the ADVOCATE program, which aims to develop FDA-authorized digital health agents for heart patients. This initiative is part of Microsoft's expansion into AI and healthcare across global markets. The company has also named Miki Tsusaka and Yang Hou as co-presidents for Asia, reflecting a refreshed leadership structure in one of its key regions.

This dual leadership move in Asia comes as Microsoft expands its AI and healthcare initiatives worldwide. With an existing footprint in cloud, productivity, and developer tools, the company can plug AI-driven healthcare agents into infrastructure that many customers already use. This could potentially support durable, high-margin growth for Microsoft.

The ADVOCATE collaboration is seen as a catalyst for Microsoft's agentic AI story, which pushes the company's technology into regulated healthcare. The Asia co-president structure also speaks to the risk of heavy AI and cloud investment, depending on winning and retaining large regional workloads.